Medical management of osteoarthritis of the knee and hip joints

被引:36
作者
Grainger, R [1 ]
Cicuttini, FM [1 ]
机构
[1] Alfred Hosp, Dept Rheumatol, Prahran, Vic 3181, Australia
关键词
D O I
10.5694/j.1326-5377.2004.tb05892.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoarthritis is a common, chronic condition which requires an individualised management plan involving multiple kinds of treatment. Exercise programs and the Arthritis Self-Management Program reduce pain and disability associated with osteoarthritis. Paracetamol is the most appropriate first-line analgesic. Non-steroidal anti-inflammatory drugs may be used as second-line analgesia on an as-needed basis (including continuous use), but must be used with caution. Cyclo-oxygenase-2-specific inhibitors are used if there are risk factors for upper-gastrointestinal complications, but only after considering cardiovascular risk. Glucosamine sulfate is a safe and effective over-the-counter treatment. Intra-articular therapies are used when others have failed.
引用
收藏
页码:232 / 236
页数:5
相关论文
共 41 条
[1]   The role of viscosupplenentation with hylan G-F 20 (Synvisc(R)) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone [J].
Adams, ME ;
Atkinson, MH ;
Lussier, AJ ;
Schulz, JI ;
Siminovitch, KA ;
Wade, JP ;
Zummer, M .
OSTEOARTHRITIS AND CARTILAGE, 1995, 3 (04) :213-225
[2]  
Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905
[3]  
*ARTHR FDN AUSTR, 2001, PREV COST DIS BURD A
[4]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[5]   Therapeutic arthroscopy for knee osteoarthritis: time to reconsider? [J].
Chapman, AB ;
Feller, JA .
MEDICAL JOURNAL OF AUSTRALIA, 2003, 179 (04) :179-180
[6]  
Cohen M, 2003, J RHEUMATOL, V30, P523
[7]  
Creamer P, 1999, Curr Opin Rheumatol, V11, P417, DOI 10.1097/00002281-199909000-00016
[8]  
*CSI PRESCR GROUP, 2002, MED J AUSTRALIA, V176, P328
[9]  
DEAL CL, 1991, CLIN THER, V13, P383
[10]   WEIGHT-LOSS REDUCES THE RISK FOR SYMPTOMATIC KNEE OSTEOARTHRITIS IN WOMEN - THE FRAMINGHAM-STUDY [J].
FELSON, DT ;
ZHANG, YQ ;
ANTHONY, JM ;
NAIMARK, A ;
ANDERSON, JJ .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :535-539